🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Currently, for further improved survival outcome, new cytotoxic compounds s...
Status
Completed
Location
Severance Hospital, Yonsei University Health System, Yonsei Cancer Center
Start Date
2013-07
Trial ID
NCT02495493
Treatments Being Tested
To evaluate the efficacy and safety of Serplulimab in Combination With Doce...
Status
Unknown
Location
Zhang Zizhen
Start Date
2023-03-01
Trial ID
NCT05769725
Treatments Being Tested
The purpose of this study is to assess efficacy and safety of docetaxel alo...
Status
Unknown
Location
Research Institute and Hospital, National Cancer Center Korea
Start Date
2008-11
Trial ID
NCT00980603
Treatments Being Tested
This study will evaluate the efficacy of docetaxel and S-1 combination chem...
Status
Unknown
Location
Hallym University Medical Center
Start Date
2011-11
Trial ID
NCT01693432
Treatments Being Tested
To evaluate the Safety and Efficacy of HIPEC Combined With Sintilimab for G...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-01-01
Trial ID
NCT05648487
Treatments Being Tested
The clinical trial aims to assess the efficacy and safety of Tislelizumab c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12-01
Trial ID
NCT06682182
Treatments Being Tested
The purpose of this observational study is to evaluate the impact of differ...
Status
Completed
Location
Jiangsu Cancer Hospital
Start Date
2019-11-01
Trial ID
NCT07098104
Treatments Being Tested
A single-arm phase II study to evaluate the efficacy and safety of docetaxe...
Status
Unknown
Location
Rongbo Lin
Start Date
2017-06-01
Trial ID
NCT03137004
The goal of the study is to learn about Safety and efficacy of preoperative...
Status
Completed
Location
Tangdu hospital
Start Date
2021-01-01
Trial ID
NCT06440811
To evaluate the efficacy and safety of Camrelizumab in Combination With Doc...
Status
Unknown
Location
Ethics Committee of Renji Hospital, School of Medicine, Shanghai Jiaotong University
Start Date
2020-04-14
Trial ID
NCT04152889
Treatments Being Tested